PRQR
ProQR Therapeutics BV
NASDAQ: PRQR · HEALTHCARE · BIOTECHNOLOGY
$1.57
+1.95% today
Updated 2026-04-30
Market cap
$155.93M
P/E ratio
—
P/S ratio
9.54x
EPS (TTM)
$-0.47
Dividend yield
—
52W range
$1 – $3
Volume
0.6M
ProQR Therapeutics BV (PRQR) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
6 of 8
Last 8 quarters
Avg EPS surprise
-6.2%
Last 4 quarters
Revenue YoY growth
+7.8%
Most recent quarter
EPS YoY growth
-2.9%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-5.0%
Last 2 reports
Positive reaction rate
0%
0 of 2 quarters
Largest single-day move
-6.7%
2025-11-06
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-02-19 | $-0.09 | -4.6% | $1.49 | $1.44 | -3.4% |
| 2025-11-06 | $-0.10 | +0.2% | $2.38 | $2.22 | -6.7% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.09 | $-0.09 | -4.6% | $4.64M | +7.8% |
| 2025-09-30 | $-0.10 | $-0.10 | +0.2% | $2.92M | -24.1% |
| 2025-06-30 | $-0.08 | $-0.12 | -50.9% | $3.82M | -39.5% |
| 2025-03-31 | $-0.16 | $-0.11 | +30.6% | $4.52M | +1.6% |
| 2024-12-31 | $-0.09 | $-0.09 | +4.9% | $4.31M | +31.2% |
| 2024-09-30 | $-0.11 | $-0.10 | +5.7% | $3.84M | +180.5% |
| 2024-06-30 | $-0.13 | $-0.03 | +76.9% | $6.30M | +407.2% |
| 2024-03-31 | $-0.11 | $-0.09 | +18.2% | $4.45M | +538.5% |
| 2023-12-31 | $0.01 | $-0.07 | -800.0% | $3.28M | — |
| 2023-09-30 | $-0.09 | $-0.07 | +22.2% | $1.37M | — |
| 2023-06-30 | $-0.11 | $-0.10 | +9.1% | $1.24M | — |
| 2023-03-31 | $-0.12 | $-0.11 | +8.3% | $697000.00 | — |
| 2022-12-31 | $-0.16 | $-0.16 | +0.0% | — | — |
Frequently asked questions
Has ProQR Therapeutics BV beaten earnings estimates?
ProQR Therapeutics BV has beaten Wall Street EPS estimates in 6 of its last 8 quarterly reports, with an average EPS surprise of -6.2% over the last 4 quarters.
How does PRQR stock react to earnings?
PRQR stock has moved an average of -5.0% in the trading day following earnings over its last 2 reports, with positive reactions in 0% of those quarters.
What is ProQR Therapeutics BV's revenue growth rate?
ProQR Therapeutics BV reported year-over-year revenue growth of +7.8% in its most recent quarter, with EPS growing -2.9% year-over-year.